Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network

Physiology and Behavior

Volumn 107, Issue 5, 2012, Pages 733-742

  Johnson, Philip L ^a   Samuels, Brian C ^a   Fitz, Stephanie D ^a   Federici, Lauren M ^a   Hammes, Nathan ^a,d   Early, Maureen C ^c,d   Truitt, William ^a   Lowry, Christopher A ^b,c   Shekhar, Anantha ^a,e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF NOTRE DAME   (United States)

^e Indiana Clinical and Translational Sciences Institute   (United States)

Author keywords

Amygdala; Anxiety; Bed nucleus of the stria terminalus; Benzodiazepine; BNST; FG 7142; GABA; Hypocretin; Hypothalamus; Orexin; Panic; Periaqueductal gray; Rostroventrolateral medulla

Indexed keywords

CAFFEINE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; OREXIN 1 RECEPTOR; PROTEIN C FOS;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BRAIN REGION; CELL ACTIVATION; CONTROLLED STUDY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; HEART RATE; IMMUNOHISTOCHEMISTRY; LATERAL HYPOTHALAMUS; MALE; MEDULLA OBLONGATA; NERVE CELL NETWORK; NEUROMODULATION; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STRIA TERMINALIS;

AMYGDALA; ANIMALS; BRAIN; CAFFEINE; CARBOLINES; CENTRAL NERVOUS SYSTEM STIMULANTS; GABA ANTAGONISTS; HYPOTHALAMUS; MALE; MEDULLA OBLONGATA; PANIC; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SEPTAL NUCLEI;

EID: 84870689509     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.04.016     Document Type: Article

References (59)

1. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998, 95:322-327.
2. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
3. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
4. Suzuki M., Beuckmann C.T., Shikata K., Ogura H., Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res 2005, 1044:116-121.
5. Samson W.K., Taylor M.M., Follwell M., Ferguson A.V. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 2002, 104:97-103.
6. Shirasaka T., Kunitake T., Takasaki M., Kannan H. Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions. Regul Pept 2002, 104:91-95.
7. Shirasaka T., Nakazato M., Matsukura S., Takasaki M., Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol 1999, 277:R1780-R1785.
8. Johnson P.L., Samuels B.C., Fitz S.D., Lightman S.L., Lowry C.A., Shekhar A. Activation of the orexin 1 receptor is a critical component of CO(2)-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacology Mar 28 2012, [Electronic publication ahead of print]. doi:10.1038/npp.2012.38.
9. Johnson P.L., Truitt W., Fitz S.D., Minick P.E., Dietrich A., Sanghani S., et al. A key role for orexin in panic anxiety. Nat Med 2010, 16:111-115.
10. Adamec R.E. Evidence that long-lasting potentiation in limbic circuits mediating defensive behaviour in the right hemisphere underlies pharmacological stressor (FG-7142) induced lasting increases in anxiety-like behaviour: role of benzodiazepine receptors. J Psychopharmacol 2000, 14:307-322.
11. Dorow R., Horowski R., Paschelke G., Amin M. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet 1983, 2:98-99.
12. Lin A.S., Uhde T.W., Slate S.O., McCann U.D. Effects of intravenous caffeine administered to healthy males during sleep. Depress Anxiety 1997, 5:21-28.
13. Minor T.R., Rowe M.K., Soames Job R.F., Ferguson E.C. Escape deficits induced by inescapable shock and metabolic stress are reversed by adenosine receptor antagonists. Behav Brain Res 2001, 120:203-212.
14. Singewald N., Salchner P., Sharp T. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 2003, 53:275-283.
15. Singewald N., Sharp T. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 2000, 98:759-770.
16. Paxinos G., Watson C. The rat brain stereotaxic coordinates 1997, Academic Press, San Diego.
17. Shekhar A., Keim S.R., Simon J.R., McBride W.J. Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions. Pharmacol Biochem Behav 1996, 55:249-256.
18. Ishii Y., Blundell J.E., Halford J.C., Upton N., Porter R., Johns A., et al. Anorexia and weight loss in male rats 24h following single dose treatment with orexin-1 receptor antagonist SB-334867. Behav Brain Res 2005, 157:331-341.
19. Harris G.C., Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci 2006, 29:571-577.
20. DiMicco J.A., Samuels B.C., Zaretskaia M.V., Zaretsky D.V. The dorsomedial hypothalamus and the response to stress: part renaissance, part revolution. Pharmacol Biochem Behav 2002, 71:469-480.
21. DiMicco J.A., Abshire V.M., Hankins K.D., Sample R.H., Wible J.H. Microinjection of GABA antagonists into posterior hypothalamus elevates heart rate in anesthetized rats. Neuropharmacology 1986, 25:1063-1066.
22. Samuels B.C., Zaretsky D.V., DiMicco J.A. Dorsomedial hypothalamic sites where disinhibition evokes tachycardia correlate with location of raphe-projecting neurons. Am J Physiol Regul Integr Comp Physiol 2004, 287:R472-R478.
23. Shekhar A. GABA receptors in the region of the dorsomedial hypothalamus of rats regulate anxiety in the elevated plus-maze test. I. Behavioral measures. Brain Res 1993, 627:9-16.
24. Brandao M.L., Zanoveli J.M., Ruiz-Martinez R.C., Oliveira L.C., Landeira-Fernandez J. Different patterns of freezing behavior organized in the periaqueductal gray of rats: association with different types of anxiety. Behav Brain Res 2008, 188:1-13.
25. Johnson P.L., Lightman S.L., Lowry C.A. A functional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic. Ann N Y Acad Sci 2004, 1018:58-64.
26. Thompson R.H., Swanson L.W. Organization of inputs to the dorsomedial nucleus of the hypothalamus: a reexamination with Fluorogold and PHAL in the rat. Brain Res Brain Res Rev 1998, 27:89-118.
27. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety?. Biol Psychiatry 1998, 44:1239-1247.
28. Davis M., Shi C. The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?. Ann N Y Acad Sci 1999, 877:281-291.
29. Davis M., Walker D.L., Lee Y. Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philos Trans R Soc Lond B Biol Sci 1997, 352:1675-1687.
30. Walker D.L., Toufexis D.J., Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 2003, 199-216.
31. Walker D.L., Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 1997, 17:9375-9383.
32. Cassell M.D., Freedman L.J., Shi C. The intrinsic organization of the central extended amygdala. Ann N Y Acad Sci 1999, 877:217-241.
33. McDonald A.J. Is there an amygdala and how far does it extend? An anatomical perspective. Ann N Y Acad Sci 2003, 985:1-21.
34. Alheid G.F., Beltramino C.A., De Olmos J.S., Forbes M.S., Swanson D.J., Heimer L. The neuronal organization of the supracapsular part of the stria terminalis in the rat: the dorsal component of the extended amygdala. Neuroscience 1998, 84:967-996.
35. Dong H.W., Petrovich G.D., Watts A.G., Swanson L.W. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol 2001, 436:430-455.
36. Dong H.W., Swanson L.W. Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J Comp Neurol 2004, 468:277-298.
37. Spencer S.J., Buller K.M., Day T.A. Medial prefrontal cortex control of the paraventricular hypothalamic nucleus response to psychological stress: possible role of the bed nucleus of the stria terminalis. J Comp Neurol 2005, 481:363-376.
38. Ter Horst G.J., Luiten P.G. The projections of the dorsomedial hypothalamic nucleus in the rat. Brain Res Bull 1986, 16:231-248.
39. Hammack S.E., Richey K.J., Watkins L.R., Maier S.F. Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behav Neurosci 2004, 118:443-448.
40. Sullivan G.M., Apergis J., Bush D.E., Johnson L.R., Hou M., Ledoux J.E. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 2004, 128:7-14.
41. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001, 435:6-25.
42. Truitt W., Johnson P.J., Dietrich A., Kelley P.E., Fitz S.D., Shekhar A. Anxiety-like responses induced by orexin A in the BNST are attenuated by NMDA antagonism 2009, Society for Neuroscience.
43. Killcross S., Robbins T.W., Everitt B.J. Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature 1997, 388:377-380.
44. Kalin N.H., Shelton S.E., Davidson R.J. The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate. J Neurosci 2004, 24:5506-5515.
45. Bisetti A., Cvetkovic V., Serafin M., Bayer L., Machard D., Jones B.E., et al. Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 2006, 142:999-1004.
46. Kayaba Y., Nakamura A., Kasuya Y., Ohuchi T., Yanagisawa M., Komuro I., et al. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 2003, 285:R581-R593.
47. Furlong T.M., Carrive P. Hypocretin/orexin neurons and the perifornical hypothalamus play a more important role in contextual fear than in restraint stress 2005, Society for Neuroscience.
48. Ross C.A., Ruggiero D.A., Park D.H., Joh T.H., Sved A.F., Fernandez-Pardal J., et al. Tonic vasomotor control by the rostral ventrolateral medulla: effect of electrical or chemical stimulation of the area containing C1 adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin. J Neurosci 1984, 4:474-494.
49. Yamada K.A., McAllen R.M., Loewy A.D. GABA antagonists applied to the ventral surface of the medulla oblongata block the baroreceptor reflex. Brain Res 1984, 297:175-180.
50. Ciriello J., Li Z., de Oliveira C.V. Cardioacceleratory responses to hypocretin-1 injections into rostral ventromedial medulla. Brain Res 2003, 991:84-95.
51. Antunes V.R., Brailoiu G.C., Kwok E.H., Scruggs P., Dun N.J. Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1801-R1807.
52. Chen C.T., Hwang L.L., Chang J.K., Dun N.J. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am J Physiol Regul Integr Comp Physiol 2000, 278:R692-R697.
53. Machado B.H., Bonagamba L.G., Dun S.L., Kwok E.H., Dun N.J. Pressor response to microinjection of orexin/hypocretin into rostral ventrolateral medulla of awake rats. Regul Pept 2002, 104:75-81.
54. Graeff F.G., Viana M.B., Mora P.O. Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 1997, 21:791-799.
55. Evans A.K., Lowry C.A. Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects. CNS Drug Rev 2007, 13:475-501.
56. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007, 8:171-181.
57. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 1980, 2:219-238.
58. Shekhar A., Keim S.R. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J Neurosci 1997, 17:9726-9735.
59. Hess W.R., Brugger M. Das subkortikake Zenrrumder affektriven Abwehrreaktion. Helv Physiol Acta 1943, 1:33-52.